Introduction
============

Globally urinary tract infection (UTI) continues to be a major public health issue. It is the second most common type of infection in the human body and the most common bacteria[@R1] infection.[@R1] Each year, about 8.1 million people visit health care providers as a result of urinary tract infections.[@R2] In 2014, UTIs accounted for 0.8% of all admissions in Ghana.[@R3] UTIs occur when microbial organisms colonize the urinary tract. Clinically, UTIs are classified as being either uncomplicated or complicated. Urinary tract infections are caused by both Gram-positive and Gram-negative bacteria, as well as by some fungi and viruses. In the diagnosis of urinary tract infections, the gold standard is the detection of the pathogen in urine in the presence of clinical symptoms.[@R4] Mid-stream urine is cultured to detect and identify the pathogen.

Internationally, the minimum level of bacteria in urine that demonstrate an infection has not been clearly defined or standardized by microbiological laboratories.[@R5] Many laboratories have defined 10^5^ colony forming units (cfu) per ml of urine as the threshold for an infection. Some other researchers recommend that urinary tract infection can be diagnosed from a count of 10^3^cfu/ml.[@R5] Since culturing urine is labour intensive and time consuming, many physicians rely on urinalysis for rapid diagnostic reports. Urinalysis has three components, physical examination, chemical examination and microscopic examination. Bacteriuria can be detected chemically and microscopically.

Bacteria in urine are chemically detected when bacteria convert nitrates to nitrites. This biochemical reaction is usually associated with bacteria of the family Enterobacteria.

However other uropathogens such as *S. saprophyticus, Pseudomonas* species, and *Enterococci* do not produce nitrite and this limits the usefulness of the test.[@R6] The presence of white blood cells (WBCs) in urine can be detected by the use of the leukocyte esterase test. Men normally have fewer than 2 WBCs per high power fields (HPF), whilst women normally have fewer than 5 WBCs per HPF.[@R7],[@R8] Some studies have been conducted to evaluate the usefulness of some parameters of urine analysis in predicting urine culture positivity.[@R9],[@R10]

Chemotherapy has been very useful in the management of UTIs over the years. However, certain practices such as inappropriate dosing and duration of antibiotic therapy and over the counter availability of antibiotics have contributed to the emergence of antibiotic drug resistance among the common pathogens.[@R11] Clinicians usually start treating suspected UTIs empirically even before urine culture results are available. Therefore to ensure that drugs prescribed are appropriate, clinicians must have knowledge on the susceptibility patterns of the known common causative organisms to available drugs in their settings.[@R12]

This is very important because causative agents of UTIs and their susceptibility trends vary in geographical locations, even within the same country. Such patterns may also change with time.[@R13] In Ghana, a number of studies have been done to identify the common causative organisms and in some cases the susceptibility patterns in different populations such as pregnant women[@R14], infants and people with urinary tract pathologies.[@R15],[@R16] However, there is a paucity of data from the present study area, Cape Coast, Ghana on the common causative agents of UTIs and their susceptibility patterns among the general population.

Our search in published literature found no study in our setting that had evaluated the usefulness of urinalysis in the diagnosis of urine tract infection even though clinicians commonly rely on it in the diagnosis of UTI instead of the more laborious and time consuming urine culture. This study therefore seeks to determine the prevalence of local bacteria isolates from suspected UTI out patients and their susceptibility to recommended drugs for use in the treatment of UTIs in the University of Cape Coast Hospital.

The study also ascertained the utility of nitrite test, leukocyte esterase test and the presence of urinary pus cells ≥ 5 per HPF in the diagnosis of UTI. The findings of this study will be useful in improving the efficacy of empirical treatments of UTI in our setting.

Methods
=======

Study population
----------------

This was a cross sectional study carried out at the University of Cape Coast Hospital from July 2017 -- December 2017.Out-patients irrespective of age and sex sent to the laboratory as suspected cases of UTI for urinalysis were recruited into the study using systematic random sampling technique.

Patients with known factors that compromise their urinary tract or host defense, such as urinary obstruction, urinary retention caused by neurological disease, immunosuppression, pregnancy and the presence of foreign bodies such as calculi, indwelling catheters or other drainage devices were excluded from the study.

If a patient had taken antibiotics within two weeks prior to the study, he/she was excluded as well. Patients were asked to provide a clean catch midstream urine in a sterile screw capped universal container. The medical records of recruited patients were consulted to obtain information on their presenting complaints and past medical history.

Ethical approval for the study was obtained from the University of Cape Coast Institutional Review Board with a protocol ID (UCCIRB/EXT/2017/04). Permission was obtained from the management of the University of Cape Coast Hospital. All respondents gave informed consent.

Dipstick Urinalysis
-------------------

Dipstick urinalysis was done using Combur 10-Test M strips with reagent pads for semiquantitative assessment of pH, specific gravity, leukocyte esterase, nitrite, protein, glucose, ketones, urobilogen, bilirubin, and blood. Leukocyte esterase (3+) and nitrite reactions were evaluated as predictive parameters for UTI.

Microscopic Sediment Urinalysis
-------------------------------

Manual microscopic sediment inspection was performed as follows: each urine sample (10 mL) was centrifuged at 1,500 rpm for 5 min, and the supernatant was removed. At least 20 random microscopic fields were examined at X40 high power field (HPF) for each sample, and the mean number of cells and particles/HPF were calculated.

Bacterial Isolation and Identification Procedures
-------------------------------------------------

Isolation of uropathogens was performed by a surface streak procedure on both 5% sheep blood and MacConkey agar (Biomark Laboratories, Pine 411041, India) using 5µL calibrated loops for semiquantitative method and incubated aerobically at 37 °C for 24 hours, and those cultures which becomes negative at the end of 24 hours incubations were further incubated for 48 hours.

A specimen was considered positive for UTI if a single organism (pure colonies) was cultured at a concentration of ≥10^5^cfu/ml. In instances of mixed bacterial growth, the procedure was repeated with fresh samples of patients. These were done to rule out possible contamination.

Each colony, representing an isolate was picked and sub-cultured on MacConkey agar to obtain pure culture. Identification of bacteria was done by colonial morphology and standard biochemical tests.[@R17] Fungal species were identified based on colonial characteristics and direct wet preparation.

Antimicrobial Susceptibility Testing
------------------------------------

Antimicrobial susceptibility of isolates was performed by the disc diffusion assay on Muller Hinton Agar by Kirby-Bauer method.[@R17] The antibiotic discs and their concentrations were: Augmentin (30 µg), Ciprofloxacin (5µg), Ceftriaxone (30 µg), Gentamicin (10µg), Piperacilin (20µg), Amikacin (30µg), Nitrofurantoin (300µg), Nalidixic Acid (30µg), Ceftadizim (20µg), Norfloxacin (20µg), Tetracycline (30µg), and Levofloxacin (5µg).

All the antimicrobials used for the study were obtained from Biomark Laboratories, Pine 411041, India. A standard inoculum adjusted to 0.5 McFarland was swabbed on to Muller-Hinton agar (Biomark Laboratories, Pine 411041, India); antibiotic disc were dispensed after drying the plate for 3--5 minutes. The reference strains used as control were *E. coli* (ATCC 25922), *S. aureus* (ATCC25923) and *P. aeruginosa* (ATTC 27853). Inhibition zone diameters were measured to the nearest millimeter with a slide gauge and interpreted according to the CLSI guidelines.[@R19],[@R20]

Data Analysis
-------------

Data collected were entered into Microsoft excel and imported into SPSS version 20.0 for analysis. The data collected included demographic characteristics, clinical presentation, urine culture results, antimicrobial spectrum of resistance and urinalysis results.

For categorical variables, percentages were calculated. Continuous variables were described by means and standard deviations.

The sensitivity, specificity, predictive values (positive and negative) and accuracy for the parameters analyzed as predictors of UTI were calculated using positive urine culture as standard. To investigate any statistically significant association between patients\' complaints and culture positivity, chi square test of association was employed. *P* values, \<0.05 were considered significant.

Results
=======

A total of 213 urine samples were analyzed, 41.7% were from males and 57.3% from females. Uropathogens isolated and characterized were 64. These included 55 bacterial and 9 fungal isolates. This results in a UTI prevalence of 30.0% (64/213) in this study population.

The age and sex distribution of patients with UTI according to isolates and presenting complaints are given in [Tables 1a](#T1a){ref-type="table"} and [1b](#T1b){ref-type="table"} respectively. Majority (48, 75.0%) of the UTI patients were females indicating a high recovery of bacteria in female samples as compared to males. Most UTI patients were in the age group 21--40 years (35, 54.7%). The mean age of the UTI patients was 36.62±17.4 years with a range of 9--73 years.

###### 

Distribution of socio-demographic characteristics of patients with UTI according to isolates

  --------------------------------------------------------------------------------------------
  Characteristics\        Isolates                                                  
  n=64                                                                              
  ----------------------- ---------- --------- -------- -------- -------- --------- ----------
  **Sex**                                                                           

  Female                  15(23.4)   8(12.5)   4(6.3)   2(3.1)   0        8(12.5)   11(12.5)

  Male                    5(7.8)     1(1.6)    1(1.6)   3(4.7)   1(1.6)   1(1.6)    4(6.3)

  **Age group (years)**                                                             

  0--20                   5(7.8)     1(1.6)    0        2(3.1)   0        0         0

  21--40                  10(15.6)   6(9.4)    4(6.3)   2(3.1)   1(1.6)   3(4.7)    9(14.0)

  41--60                  3(4.7)     2(3.1)    1(1.6)   1(1.6)   0        1(1.6)    4(6.3)

  61--80                  2(3.1)     0         0        0        0        5(7.8)    2(3.1)
  --------------------------------------------------------------------------------------------

###### 

Distribution of socio-demographic characteristics of patients with UTI according to presenting complaints

  ------------------------------------------------------------------------------------------------------
  Characteristics\        Presenting complaints                                               
  n=64                                                                                        
  ----------------------- ----------------------- ---------- ---------- ---------- ---------- ----------
  **Sex**                                                                                     

  Female                  27(42.2)                19(29.7)   13(20.3)   18(28.1)   8(12.5)    15(23.4)

  Male                    12(18.8)                15(23.4)   27(42.2)   6(9.4)     12(18.8)   10(15.6)

  **Age group (years)**                                                                       

  0--20                   5(7.8)                  1(1.6)     6(9.4)     7(10.9)    6(9.4)     8(12.5)

  21--40                  15(23.4)                12(18.8)   21(32.8)   5(7.8)     9(14.0)    8(12.5)

  41--60                  10(15.6)                12(18.8)   8(12.5)    10(15.6)   1(1.6)     6(9.4)

  61--80                  5(7.8)                  6(9.4)     5(7.8)     2(3.1)     4(6.3)     3(4.7)
  ------------------------------------------------------------------------------------------------------

The most frequently isolated pathogen was *E. coli* (20, 31.2%), followed by *S. saprophyticus* (9, 14.1%) and *Enterobacter* (5, 7.8%). *Candida* species were isolated in 9 (14.1%) patients, eight of whom were females. ([Tables 1a](#T1a){ref-type="table"} and [1b](#T1b){ref-type="table"}).

The overall susceptibility profiles of the isolated pathogens are shown in [Table 2](#T2){ref-type="table"}. Most bacteria isolated (52, 94.5%) were sensitive to Amikacin, followed by Ciprofloxacin (42, 76.3%). The bacteria were least susceptible to Augmentin (10, 18.2%), Nalidixic (13, 23.6%) acid and Tetracycline (13, 23.6%) ([Figure 1](#F1){ref-type="fig"})

###### 

Antibiotic sensitivity and resistance pattern of isolated bacteria in UTI

  Antibiotic         Isolates                                                                          
  ------------------ ---------- -------- --------- --------- ------- ------- ------- -------- -------- ---------
  *Augmentin*        18(90)     2(10)    9(100)    0         4(80)   1(20)   4(80)   1(20)    14(56)   11(44)
  *Ciprofloxacin*    6(30)      14(70)   2(22.2)   7(77.8)   1(20)   4(80)   1(20)   4(80)    3(12)    22(88)
  *Ceftriaxone*      12(60)     8(300    4(44.5)   5(55.5)   3(60)   2(40)   4(80)   1(20)    6(24)    19(76)
  *Gentamicin*       9(45)      11(55)   2(22.2)   7(77.8)   3(60)   2(40)   4(80)   1(20)    10(40)   15(60)
  *Piperacilin*      5(25)      15(75)   7(77.8)   2(22.2)   2(40)   3(60)   2(40)   3(60)    6(24)    19(76)
  *Amikacin*         2(10)      18(90)   0         9(100)    2(20)   4(80)   0       5(100)   0        100
  *Nitrofurantoin*   3(15)      17(85)   0         9(100)    3(60)   2(40)   3(60)   2(40)    12(48)   13(52)
  *Nalidixic acid*   15(75)     5(25)    8(88.9)   1(11.1)   4(80)   1(20)   3(60)   2(40)    18(72)   7(28)
  *Ceftadizime*      8(40)      12(60)   7(77.8)   2(22.2)   2(40)   3(60)   4(80)   1(20)    18(72)   7(28)
  *Norfloxacin*      8(40)      12(60)   4(44.5)   5(55.5)   2(40)   3(60)   3(60)   2(40)    5(20)    20(80)
  *Tetracycline*     20(100)    0        5(55.5)   4(44.5)   4(80)   1(20)   3(60)   2(40)    19(76)   6(24)
  *levofloxacin*     5(25)      15(75)   4(44.5)   5(55.5)   3(60)   2(40)   3(60)   2(40)    0        25(100)

S=Sensitive, R=Resistant
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The most sensitive of the parameters was urine pus cells \>5 WBC per HPF (94.4%) and the least sensitive was the nitrite test (21.0%). The nitrite test was however the most specific parameter with a specificity of 98.9%, followed by the leukocyte esterase test (94.9%) which had an accuracy of 91.1% ([Table 3](#T3){ref-type="table"}).

###### 

Comparison of urinalysis parameters with urine culture in the detection of UTI

  -------------------------------------------------------------------------------------------------------------------------------------------
  *Screening test*                    *Sensitivity (%)*   *Specificity (%)*   *Positive*\           *Negative predictive*\   *Accuracy (%)*
                                                                              *predictive value*\   *value (%)*              
                                                                              *(%)*                                          
  ----------------------------------- ------------------- ------------------- --------------------- ------------------------ ----------------
  *Nitrite*                           21.0                98.9                80.0                  84.5                     85.9

  *Leukocyte esterase*                57.6                94.9                74.2                  94.4                     91.1

  *Urinary Pus Cell Count ≥ 5/ hpf*   94.4                75.0                43.0                  98.5                     77.9
  -------------------------------------------------------------------------------------------------------------------------------------------

Significantly higher proportion of UTI patients reported that they had experienced polyuria (p=0.002), burning sensation upon passing urine (p=0.020 and painful urination (p=0.038) as compared to non-UTI subjects ([Table 4](#T4){ref-type="table"})

###### 

Presenting complaints of suspected UTI patients and the results of their urine analysis and urine culture

                         Urine culture   *p-values*   Urine Analysis Parameters                        
  ---------------------- --------------- ------------ --------------------------- -------- ----------- -----------
  Polyuria               35 (54.6)       49 (32.9)    0.002                       8 (80)   5 (14.3)    46 (58.2)
  Burning sensation      34 (53.1)       54 (36.2)    0.028                       3 (30)   22 (62.9)   14 (17.70
  Painful urination      40 (62.5)       70 (47.0)    0.038                       4 (40)   30 (85.7)   69 (90.8)
  Lower abdominal pain   24 (37.5)       49 (32.9)    0.515                       5 (50)   11 (31.4)   15 (19.0)
  Fever                  20 (31.5)       60 (40.3)    0.212                       0        4 (11.4)    12 (15.2)
  General body pains     25 (39.0)       54 (36.2)    0.696                       0        3 (8.6)     8 (10.1)

patients with pure growth of a single bacteria species

Discussion
==========

The prevalence of UTI among the study population was 30.0% which is relatively higher than the prevalence of 15.9% reported in an earlier study in Ghana[@R15] and a rate of 6.3% found in an India study.[@R21] The prevalence rate found in this study was however lower than the rate of 57.2% reported from Nigeria.[@R22] The difference in the prevalence rates could be due to the difference in study designs, study sites, years between the studies and the definitions of UTI used in the study.

These earlier studies did not investigate fungal urinary tract infections. The incidence of UTI was higher in females (71.9%) compared to males (28.1%). Several studies conducted globally have reported similar differences in incidence of UTI between the genders.[@R23] This has been attributed to the differences in the anatomy and physiology of the urinary and reproductive system of males and females.[@R23] Evaluation for the presence of nitrites has been shown to be of value in the diagnosis of UTI.

The sensitivity and specificity of the nitrite test in this study were 21.0% and 98.9% respectively.

This finding is similar to that of some earlier studies that also found the nitrite test to be highly specific but generally insensitive.[@R7],[@R10]

The high specificity and negative predictive value of the nitrite test in this setting indicate that a negative result virtually rules out UTI. This could probably be due to the fact that many of the uropathogens found in this study are capable of reducing nitrate to nitrites.[@R6] The leukocyte esterase test had a sensitivity of 57.6% and a specificity of 94.9%. Other studies had also found the leukocyte esterase test to be insensitive.[@R10],[@R24]

The low sensitivity of the test limits its utility in diagnosing uncomplicated UTI in our setting. However a negative leukocyte esterase test result due to the high specificity and high negative predictive value could be used to screen for urine that do not need to be cultured.

The high sensitivity (94.4%) and low specificity (75.0%) of pyuria (\>5 WBC per HPF) found in this study is similar to what was found in a review conducted by Simerville et al..[@R7]

The high sensitivity of this test makes it important in the diagnosis of UTI in our setting. A positive test virtually confirms the disease even though there could be false positives. The test was also found to have a high negative predictive value (98.5%). This means that a negative test result very nearly eliminates the presence of UTI. According to the American Academy of Family Physicians uncomplicated urinary tract infections diagnosed by positive leukocyte esterase and nitrite tests can be treated without culture.[@R7]

The study found a strong association between some clinical presentations and the occurrence of positive urine cultures. These patient\' complaints were frequent urination, burning sensation associated with urination and pain on urination. These findings agree with what was reported by Thakre et al..[@R25] Typical history of UTI has been known to include pain on urination, frequency, urgency and haematuria.[@R26]

The findings of this study therefore suggest that patients who presents with frequent urination, burning sensation associated with urination and pain on urination are more likely to have UTI and could be considered for empirical treatment. Previous studies had shown that sensitivity based on a typical history is between 50% and 80%.[@R26],[@R27]

*E. coli* was found to be the commonest pathogen responsible for UTI in our setting. Many previous studies conducted in different parts of the globe have also found *E. coli* as the most implicating pathogen isolated in UTI patients.[@R28] *S. saprophyticus* was found to be the second leading cause of UTI in our setting. Similar findings have been observed by other workers.[@R29],[@R30]

It is the second most common causative agent of UTI in young women worldwide.[@R30] The high incidence of *S. saprophyticus* urinary tract infection in this study brings to light its emerging prominence as an aetiological agent of UTI.

The most frequently isolated uropathogen *E. coli* was found to be highly sensitive to Amikacin (90%), followed by Nitrofurantoin (85%), Levofloxacin (75%) and Ciprofloxacin (70%). This high sensitivity of uropathogens to Amikacin had been observed by other workers as well.[@R31] *E. coli* was found to be most resistant to Tetracycline and Augmentin.

This correlates with the findings of some other studies.[@R32] *S. saprophyticus* was most sensitive to Amikacin (100%) and Nitrofurantoin (100%). High sensitivity was also observed to Gentamicin (77.8%), and Ciprofloxacin (77.8%).

Similar sensitivity of *S. saprophyticus* to Gentamicin and Ciprofloxacin had been reported by earlier researchers.[@R30] Overall, most isolates (94.5%) were sensitive to Amikacin, followed by Ciprofloxacin (76.3%).

This study revealed that Augmentin, Nalidixic acid and Tetracycline were virtually useless against the uropathogens as they were effective against only 18.2%, 23.6% and 23.6% of all bacteria isolates respectively. Thus in our setting, the drug of choice for treating uncomplicated UTI is Amikacin followed by Ciprofloxacin. Amikacin is an aminoglycoside antibiotic, which is usually given by the intravenous and intramuscular routes. There is no oral form available as it cannot be absorbed orally. This limits its use among out patients. Its use for out-patients could also lead to the selection of resistant strains. Ciprofloxacin, which is a fluoroquinolone is available in oral and intravenous formulations. It can therefore be conveniently used as the first line treatment of uncomplicated UTI in the outpatient setting. The findings of this study thus support the recommendation of the Standard Treatment Guidelines of Ghana (2017) in the use of oral ciprofloxacin as the first line treatment of uncomplicated UTI.[@R33]

This study isolated Candida species in 9 patients. Some studies have reported increasing numbers of fungal UTI, particularly those caused by *Candida spp, Aspergillus spp.* and *Cryptococcus neoformans*. In a study conducted in a general hospital, positivity for *Candida spp* was found in 5% of urine specimen and 10% from a tertiary hospital.[@R34] Diabetics are known to be particularly prone to fungal UTI.[@R35] This finding indicates that clinicians should give consideration to fungal UTI in our setting especially in patients with persistent symptoms after course of standard treatment. The main stay of treatment for symptomatic candiduria is fluconazole 200 mg daily for 2 weeks.[@R36]

Conclusions
===========

The prevalence of UTI in this study was high (30.0%). Most isolates were sensitive to amikacin and ciprofloxacin. Our findings support the recommendation of the use of oral ciprofloxacin as the first line treatment of uncomplicated UTI by the Ghana Standard Treatment Guidelines (2017).

[^1]: **Conflict of interest:** None declared
